- Biotechnology
- Tuesday, 25 Feb 2020
Hansa Biopharma to Participate in Two Upcoming Investor Conferences
Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, announced that the Company's management team will participate in the following upcoming investor conferences:
- Cowen and Company's 40th Annual Health Care Conference in Boston on Monday, March 2, 2020, with a presentation at 4:10 PM EST/ 22:10 CET on the same day.
- The Carnegie Nordic Healthcare Seminar in Stockholm on Wednesday, March 4, 2020, with a presentation at 8:00 AM CET
A live webcast of the Cowen presentation will be available on the Events & Webcast page of the Company's website, www.hansabiopharma.com . A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.
Calendar 2020
| Feb 27-28, 2020 | Road Show Cowen, Chicago/Dallas |
| Mar 2, 2020 | Cowen Annual Health Care Conference, Boston |
| Mar 4, 2020 | Road Show Argot, New York City |
| Mar 4, 2020 | Carnegie Nordic Healthcare Seminar, Stockholm |
| Mar 26, 2020 | Kempen Expert Call with Prof. Mårten Segelmark on Anti-GBM |
| Apr 2, 2020 | Annual Report 2019 |
| Apr 21-22, 2020 | Kempen Life Sciences Conference, Amsterdam |
| Apr 28, 2020 | Interim Report Jan-Mar 2020 |
| May 5, 2020 | Annual General Meeting |
| May 18, 2020 | UBS Global Healthcare Conference, NYC |
| May 19, 2020 | RBC Global Healthcare Conference, NYC |
| May 26, 2020 | ABG Life Science Summit, Stockholm |
| May 27, 2020 | Ökonomisk Ugebrev Life Science Conference, Copenhagen |
| Jul 16, 2020 | Interimn Report Jan-Jul 2020 |
| Sep 16-17, 2020 | Bank of America Merill Lynch Global Healthcare Conf., London |
| Oct 22, 2020 | Interimn Report Jan-Sep 2020 |
Related Industry Updates
Absorbable Surgical Sutures Market Foreseen to Grow Exponentially by 2027
Dec 16, 2020
Bioremediation Technology And Services Market Set To Witness Adamant Growth with Forecast 2021-2027 with Top InSitu Remediation Services Limited, PROBIOSPHERE, Ivey International, Inc., Sumas Remediation Services, Inc.,Sarva Bio Remed, LLC.
Apr 06, 2021
ELISA Diagnostic Test Market is expected to reach US$ 2,271.23 million by 2030
Nov 02, 2023
Stem Cell Therapy Market Supply, Growth Rate by Segments to 2021- 2027
Mar 25, 2021
Increasing technological advancements is expected to bolster the gene synthesis market
Aug 31, 2019
Analyzing Impacts Of COVID-19 On Fundus Cameras Market Effects, Aftermath And Forecast To 2027
Apr 20, 2021
Bioburden Testing Market 2020 Production, Revenue, Industry Market Share, Regional Growth Analysis, Upcoming Trends, Key Manufacturers, Development Analysis Research Report by 2027
Jan 05, 2021
Follow us on
